THOR MEDICAL ASA

0278 OSLO

Finances

Share Ownership

Return on Equity

−487,52 %

Current Ratio

2,46

Debt-to-Equity Ratio

0,02

Key figures (NOK)	2022	2021	2020	2019
Revenue	0	0	0	0
Net Income	−311 241 000	−441 303 000	−417 075 000	−433 597 000
Total Assets	109 645 000	296 672 000	314 610 000	515 718 000
Total Equity	63 842 000	140 516 000	178 668 000	388 008 000

Income (NOK)	2022	2021	2020	2019
Revenue	0	0	0	0
Expenditure	317 361 000	442 434 000	434 161 000	440 352 000
Operating Profit	−317 361 000	−442 434 000	−434 161 000	−440 352 000
Financial Income	7 248 000	2 932 000	18 860 000	8 711 000
Financial Costs	259 000	636 000	860 000	1 018 000
Financial Balance	6 989 000	2 296 000	18 000 000	7 693 000
Earnings Before Tax	−310 372 000	−440 138 000	−416 161 000	−432 659 000
Tax	869 000	1 165 000	914 000	938 000
Net Income	−311 241 000	−441 303 000	−417 075 000	−433 597 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	537 000	5 943 000	5 684 000	20 395 000
Total Current Assets	109 108 000	290 729 000	308 926 000	495 323 000
Total Assets	109 645 000	296 672 000	314 610 000	515 718 000
Total Retained Equity	−25 915 000	−58 830 000	−17 146 000	−29 582 000
Total Equity	63 842 000	140 516 000	178 668 000	388 008 000
Total Long-Term Debt	1 520 000	4 461 000	7 381 000	7 919 000
Total Current Debt	44 283 000	151 695 000	128 561 000	119 791 000
Total Equity and Debt	109 645 000	296 672 000	314 610 000	515 718 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	0	0	0	0
Other Income	0	0	0	0
Revenue	0	0	0	0
Cost of Goods Sold	0	0	0	0
Salary Costs	78 527 000	91 638 000	78 301 000	96 409 000
Depreciation	11 202 000	11 371 000	14 895 000	12 659 000
Impairment	0	0	0	0
Expenditure	317 361 000	442 434 000	434 161 000	440 352 000
Operating Profit	−317 361 000	−442 434 000	−434 161 000	−440 352 000
Financial Income	7 248 000	2 932 000	18 860 000	8 711 000
Financial Costs	259 000	636 000	860 000	1 018 000
Financial Balance	6 989 000	2 296 000	18 000 000	7 693 000
Dividends	0	0	0	0
Net Income	−311 241 000	−441 303 000	−417 075 000	−433 597 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	158 000	5 177 000	4 290 000	17 747 000
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	379 000	766 000	1 394 000	2 648 000
Total Tangible Assets	379 000	766 000	1 394 000	2 648 000
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	537 000	5 943 000	5 684 000	20 395 000
Stock	0	0	0	0
Total Investments	0	0	0	0
Cash, Bank	98 716 000	277 706 000	293 975 000	470 824 000
Total Current Assets	109 108 000	290 729 000	308 926 000	495 323 000
Total Assets	109 645 000	296 672 000	314 610 000	515 718 000
Total Equity	63 842 000	140 516 000	178 668 000	388 008 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	1 520 000	4 461 000	7 381 000	7 919 000
Creditors	9 093 000	65 960 000	65 862 000	45 956 000
Unpaid Taxes	0	0	0	0
Dividends	0	0	0	0
Other Current Debt	34 431 000	84 667 000	61 896 000	72 886 000
Total Current Debt	44 283 000	151 695 000	128 561 000	119 791 000
Total Equity and Debt	109 645 000	296 672 000	314 610 000	515 718 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−487,52 %	−314,06 %	−233,44 %	−111,75 %
Debt-to-Equity Ratio	0,02	0,03	0,04	0,02
Operating Profit Margin	-	-	-	-
Current Ratio	2,46	1,92	2,4	4,13
Quick Ratio	2,46	1,92	2,4	4,13
Equity Ratio	0,58	0,47	0,57	0,75
Gross Profit Margin	-	-	-	-